We evaluated the hypothesis that impaired sarcolemmal function associa
ted with exaggerated potassium release, impaired potassium uptake, or
both may contribute to exertional fatigue and abnormal circulatory res
ponses to exercise in McArdle disease (MD). The cellular mechanism of
exertional fatigue and muscle injury in MD is unknown but likely invol
ves impaired function of the ATPases that couple ATP hydrolysis to cel
lular work, including the muscle sodium potassium pump (Na+K+-ATPase).
However, the concentration of muscle Na+K+ pumps in MD is not known,
and no studies have related exercise increases in blood potassium conc
entrations to muscle Na+K+ pump levels. We measured muscle Na+K+ pumps
(H-3-ouabain binding) and plasma K+ in response to 20 minutes of cycl
e exercise in six patients with MD and in six sex-, age-, and weight-m
atched sedentary individuals. MD patients had lower levels of H-3-ouab
ain binding (231 +/- 18 pmol/g w.w., mean +/- SD, range, 210 to 251) t
han control subjects (317 +/- 37, range, 266 to 371, p < 0.0004), high
er peak increases in plasma potassium in response to 45 +/- 7 W cycle
exercise (MD, 1.00 +/- 0.15 mmol/L; control subjects, 0.48 +/- 0.09; p
< 0.0001), and mean exercise heart rate responses to exercise that we
re 45 +/- 12 bpm greater than control subjects. Our results indicate t
hat Na+K+ pump levels are low in MD patients compared with healthy sub
jects and identify a Limitation of potassium reuptake that could resul
t in sarcolemmal failure during peak rates of membrane activation and
may promote exaggerated potassium-activated circulatory responses to s
ubmaximal exercise. The mechanism of the low Na+K+ pump concentrations
in MD is unknown but may relate to deconditioning or to disruption of
a close functional relationship between membrane ion transport and gl
ycolysis.